Stockscreener 앱 받기
47.89
4.73%
-2.38
시장 영업 전:
47.40
-0.49
-1.02%
전일 마감가:
$50.27
열려 있는:
$50.1
하루 거래량:
18.90M
Relative Volume:
0.43
시가총액:
$12.37B
수익:
$1.78B
순이익/손실:
$164.40M
주가수익비율:
69.41
EPS:
0.69
순현금흐름:
$236.51M
1주 성능:
-0.19%
1개월 성능:
-16.80%
6개월 성능:
+88.47%
1년 성능:
+127.51%
1일 변동 폭
$47.76
$50.77
1주일 범위
$45.04
$52.33
52주 변동 폭
$13.47
$72.98
Hims Hers Health Inc Stock (HIMS) Company Profile
명칭
Hims Hers Health Inc
전화
415-851-0195
주소
2269 CHESTNUT ST, SAN FRANCISCO
HIMS을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
HIMS
Hims Hers Health Inc
|
47.89 | 12.37B | 1.78B | 164.40M | 236.51M | 0.69 |
|
PG
Procter Gamble Co
|
157.05 | 381.79B | 83.93B | 15.50B | 15.03B | 6.30 |
|
UL
Unilever Plc Adr
|
60.79 | 154.84B | 65.10B | 6.16B | 0 | 2.4569 |
|
CL
Colgate Palmolive Co
|
89.58 | 74.51B | 19.95B | 2.90B | 3.47B | 3.54 |
|
KMB
Kimberly Clark Corp
|
129.38 | 44.14B | 19.75B | 2.47B | 2.39B | 7.34 |
|
KVUE
Kenvue Inc
|
21.34 | 41.32B | 15.30B | 1.06B | 1.45B | 0.55 |
Hims Hers Health Inc Stock (HIMS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-06-04 | 재확인 | Needham | Buy |
| 2025-04-29 | 다운그레이드 | TD Cowen | Buy → Hold |
| 2025-02-18 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2025-01-10 | 다운그레이드 | Citigroup | Neutral → Sell |
| 2025-01-07 | 개시 | BTIG Research | Buy |
| 2024-12-17 | 개시 | Morgan Stanley | Overweight |
| 2024-11-14 | 다운그레이드 | BofA Securities | Buy → Underperform |
| 2024-08-22 | 개시 | Needham | Buy |
| 2024-08-09 | 다운그레이드 | Imperial Capital | Outperform → In-line |
| 2024-05-22 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2024-04-16 | 다운그레이드 | Jefferies | Buy → Hold |
| 2024-04-10 | 개시 | Canaccord Genuity | Buy |
| 2024-02-28 | 업그레이드 | Imperial Capital | In-line → Outperform |
| 2024-02-26 | 개시 | Leerink Partners | Market Perform |
| 2023-12-07 | 개시 | Imperial Capital | In-line |
| 2023-07-28 | 개시 | TD Cowen | Outperform |
| 2023-04-11 | 개시 | Robert W. Baird | Neutral |
| 2023-02-09 | 업그레이드 | Jefferies | Hold → Buy |
| 2022-11-08 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2022-11-08 | 업그레이드 | SVB Leerink | Mkt Perform → Outperform |
| 2022-10-17 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2022-09-07 | 개시 | Truist | Hold |
| 2022-07-15 | 개시 | SVB Leerink | Underperform |
| 2022-04-14 | 개시 | Guggenheim | Buy |
| 2022-04-01 | 재개 | Credit Suisse | Outperform |
| 2022-03-10 | 개시 | Deutsche Bank | Hold |
| 2021-12-02 | 개시 | Jefferies | Hold |
| 2021-11-11 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2021-07-06 | 개시 | BofA Securities | Neutral |
| 2021-05-20 | 업그레이드 | Credit Suisse | Neutral → Outperform |
| 2021-04-21 | 개시 | Truist | Hold |
| 2021-03-09 | 개시 | Credit Suisse | Neutral |
| 2021-03-02 | 업그레이드 | Citigroup | Neutral → Buy |
| 2021-02-17 | 개시 | Citigroup | Neutral |
| 2021-02-12 | 개시 | Piper Sandler | Neutral |
| 2021-02-08 | 개시 | Tigress Financial | Buy |
모두보기
Hims Hers Health Inc 주식(HIMS)의 최신 뉴스
Levi & Korsinsky Urges Hims & Hers Health, Inc. (HIMS) Shareholders to Act Before Lead Plaintiff Deadline August 25, 2025 - ACCESS Newswire
Lost Money on Hims & Hers Health, Inc. (HIMS)? Join Class Action Before August 25, 2025Contact Levi & Korsinsky - ACCESS Newswire
Lost Money on Hims & Hers Health, Inc. (HIMS)? Urged to Join Class Action Before August 25, 2025Contact Levi & Korsinsky - ACCESS Newswire
Bragar Eagel & Squire, P.C. Reminds Investors That Class - GlobeNewswire
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Hims & Hers, Sarepta, and Petco and Encourages Investors to Contact the Firm - GlobeNewswire Inc.
Hims & Hers Health, Inc. (HIMS) Isn’t Regarded As A Great Actor By Doctors, Says Jim Cramer - Insider Monkey
HIMS FRAUD ALERT: Hims & Hers Health, Inc. 34% Stock Drop - GlobeNewswire
Bull of the Day: Hims & Hers Health (HIMS) - Nasdaq
Levi & Korsinsky Reminds Hims & Hers Health, Inc. Investors - GlobeNewswire
ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Hims & Hers Health, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – HIMS - TradingView
Hims & Hers Health, Inc. (HIMS) Faces Securities Class - GlobeNewswire
Hims & Hers Health, Inc. Sued for Securities Law ViolationsInvestors Should Contact Levi & Korsinsky Before August 25, 2025 to Discuss Your RightsHIMS - Morningstar
Kirby McInerney LLP Reminds Hims & Hers Health, Inc. (HIMS) Investors of Class Action Filing and Encourages Investors to Contact the Firm - Business Wire
Class Action Filed Against Hims & Hers Health, Inc. (HIMS) - GlobeNewswire
HIMS COURT NOTICE: Hims & Hers Health, Inc. Investors may - GlobeNewswire
Hims & Hers Health, Inc. (HIMS) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit - Morningstar
Hims & Hers Announces Planned 2026 Expansion to Canada, Following ZAVA Acquisition Completion - Hims
HIMS & HERS HEALTH SHAREHOLDER ALERT BY FORMER LOUISIANA - GlobeNewswire
HIMS Investors Have the Opportunity to Lead the Hims & Hers Health Securities Fraud Lawsuit with Faruqi & Faruqi, LLP - Morningstar
Deadline Alert: Hims & Hers Health, Inc. (HIMS) Investors - GlobeNewswire
HIMS & HERS HEALTH, INC. (NYSE: HIMS) SHAREHOLDER ALERT - GlobeNewswire
Hims & Hers Health, Inc. (HIMS) Is a Trending Stock: Facts to Know Before Betting on It - Yahoo Finance
Class Action Filed Against Hims & Hers Health, Inc. (HIMS) Seeking Recovery for InvestorsContact The Gross Law Firm - The Victoria Advocate
HIMS SHAREHOLDER ALERT: Suffer Losses on Hims & Hers - GlobeNewswire
INVESTOR DEADLINE: Hims & Hers Health, Inc. (HIMS) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - PR Newswire
Hims & Hers Health’s Q1 Earnings Call: Our Top 5 Analyst Questions - Yahoo Finance
Hims & Hers Enhances Healthcare Through AI-Driven Personalization - Yahoo Finance
Hims & Hers Health, Inc. Class Action: The Gross Law Firm - GlobeNewswire
HIMS CLASS ACTION: A Class Action was filed against Hims & - GlobeNewswire
Hims & Hers Health, Inc. (HIMS) Suffers a Larger Drop Than the General Market: Key Insights - Yahoo Finance
Hims & Hers vs. LifeMD: Which Telehealth Stock Has More Upside? - Yahoo Finance
Hims & Hers’ ugly split with Wegovy maker weighs on the telehealth company’s future - Los Angeles Times
Hims & Hers (HIMS) Rallies 11.76% as CEO Not Backing Down After Novo Nordisk Spat - Yahoo Finance
Novo Nordisk ends Hims & Hers deal over Wegovy knockoffs - NJBIZ
HIMS SECURITIES: Lose Money on Hims & Hers Health, Inc. - GlobeNewswire
Law Offices of Frank R. Cruz Encourages Hims & Hers Health, Inc. (HIMS) Investors To Inquire About Securities Fraud Class Action - Business Wire
SHAREHOLDER ALERT: Hims & Hers Health, Inc. Sued For - GlobeNewswire
Novo Nordisk ends Hims & Hers partnership over GLP-1 safety concerns - TechTarget
HIMS Investors Have Opportunity to Join Hims & Hers Health, Inc. Fraud Investigation With the Schall Law Firm - Business Wire
How IBD 50's Hims & Hers Is Shaking Up The Weight-Loss Brawl - Investor's Business Daily
Hims & Hers Stock Jumps 85.1% in 3 Months: Is It a Buy Now? - Nasdaq
Hims & Hers Goes Global, Named To Top Stocks List: Build Your Growth Stock Watchlist With These Just Updated Screens - Investor's Business Daily
Where Will Hims & Hers Stock Be In 10 Years? - Barchart.com
Hims & Hers Health Inc Stock: Navigating High Volatility and a Rich Valuation - Daily Chhattisgarh News
Bet on Winning DuPont Analysis & Pick 3 Top Stocks - Yahoo Finance
Move Over Hims & Hers Health: This Insurance Business Could Be the Next Monster Healthcare Stock (Hint: It's Not UnitedHealth) - Barchart.com
Hims & Hers Health Annual Stockholders Meeting Results - TipRanks
Hims & Hers (HIMS) Stock Pauses After Explosive 134% Rally This Year, Highlighting Immense Growth - Daily Chhattisgarh News
These 2 Growth Stocks Are No-Brainer Buys Right Now - Yahoo Finance
VF Corp, MGM Resorts, PENN Entertainment, Hims & Hers Health, and Camping World Shares Are Soaring, What You Need To Know - Yahoo Finance
2 Reasons To Double Down On Hims & Hers Ahead Of August (NYSE:HIMS) - Seeking Alpha
Hims Hers Health Inc (HIMS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Hims Hers Health Inc 주식 (HIMS) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Okupe Oluyemi | Chief Financial Officer |
Jul 07 '25 |
Option Exercise |
5.01 |
6,437 |
32,249 |
69,659 |
| Okupe Oluyemi | Chief Financial Officer |
Jul 07 '25 |
Sale |
46.67 |
11,581 |
540,498 |
58,078 |
| Boughton Soleil | Chief Legal Officer |
Jun 30 '25 |
Sale |
50.50 |
2,572 |
129,886 |
160,737 |
1.02%
2.01%
자본화:
|
볼륨(24시간):